Literature DB >> 14592477

Synthesis of 17beta-estradiol platinum(II) complexes: biological evaluation on breast cancer cell lines.

Caroline Descôteaux1, Josée Provencher-Mandeville, Isabelle Mathieu, Valérie Perron, Sanat K Mandal, Eric Asselin, Gervais Bérubé.   

Abstract

The synthesis of a novel series of 17beta-estradiol-linked platinum(II) complexes is described. The new molecules are linked with an alkyl chain at position 16alpha of the steroid nucleus and bear a 16beta-hydroxymethyl side chain. They are made from estrone in five chemical steps with an overall yield exceeding 28%. The biological activity of these compounds was evaluated in vitro on estrogen dependent and independent (ER+ and ER-) human breast cancers. The derivatives incorporating a 2-(2'-aminoethyl)pyridine ligand displayed good activity against the cell lines particularly when the connecting arm is 10 carbon atoms long.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14592477     DOI: 10.1016/j.bmcl.2003.09.011

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

1.  A bifunctional platinum(II) antitumor agent that forms DNA adducts with affinity for the estrogen receptor.

Authors:  Eunsuk Kim; Peter T Rye; John M Essigmann; Robert G Croy
Journal:  J Inorg Biochem       Date:  2008-10-26       Impact factor: 4.155

Review 2.  The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.

Authors:  Timothy C Johnstone; Kogularamanan Suntharalingam; Stephen J Lippard
Journal:  Chem Rev       Date:  2016-02-11       Impact factor: 60.622

3.  Platinum (II) complex-nuclear localization sequence peptide hybrid for overcoming platinum resistance in cancer therapy.

Authors:  Marek T Wlodarczyk; Sylwia A Dragulska; Olga Camacho-Vanegas; Peter R Dottino; Andrzej A Jarzęcki; John A Martignetti; Aneta J Mieszawska
Journal:  ACS Biomater Sci Eng       Date:  2018-01-09

4.  Evaluating Ligand Modifications of the Titanocene and Auranofin Moieties for the Development of More Potent Anticancer Drugs.

Authors:  Lauren Fernandez-Vega; Valeria A Ruiz Silva; Tania M Domínguez-González; Sebastián Claudio-Betancourt; Rafael E Toro-Maldonado; Luisa C Capre Maso; Karina Sanabria Ortiz; Jean A Pérez-Verdejo; Janeishly Román González; Grecia T Rosado-Fraticelli; Fabiola Pagán Meléndez; Fabiola M Betancourt Santiago; Daniel A Rivera-Rivera; Carlos Martínez Navarro; Andrea C Bruno Chardón; Axel O Vera; Arthur D Tinoco
Journal:  Inorganics (Basel)       Date:  2020-01-26

Review 5.  Antitumor Activity of Pt(II), Ru(III) and Cu(II) Complexes.

Authors:  Katarzyna Gałczyńska; Zuzanna Drulis-Kawa; Michał Arabski
Journal:  Molecules       Date:  2020-07-31       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.